MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Immunoglobulins"

  • 2022 International Congress

    Combined anti N-Methyl-D- Aspartate receptor (NMDAR) encephalitis with autoimmune thyroiditis (AT), with good clinical recovery.

    M. Farghal, M. Abu Hashish (Ahmadi, Kuwait)

    Objective: To report anti NMDAR encephalitis patient, with evidence of AT, and to explain her clinical presentation, management and outcome. Background: Autoimmune encephalitis(AE) is nowadays…
  • MDS Virtual Congress 2021

    Immune-Mediated and Mercury Intoxication Ataxias: Anti-GAD Antibodies and Dynamic Stabilometriс Assessment

    N. Kolmykova, S. Kiryukhina, D. Labunskiy, E. Razgadova, M. Kustov (Saransk, Russian Federation)

    Objective: The goals of our study were evaluation of disequilibrium, static and dynamic functions and anti-GAD antibodies concentrations in immune mediated and mercury intoxication ataxias…
  • MDS Virtual Congress 2021

    SARS-CoV-2 Encephalopathy Presenting as Opsoclonus Myoclonus Syndrome Successfully Treated with IV Immunoglobulins

    M. Salgado, I. Hacker, A. Alport, J. Ma (Brooklyn, USA)

    Objective: To present a case of a SARS-CoV-2 patient presenting with opsoclonus myoclonus syndrome who was successfully treated with IVIGs. Background: The COVID-19 pandemic has…
  • MDS Virtual Congress 2020

    Cytokines and Brain Specific Antibodies in Experimental Cellular and Molecular Treatment of Huntington’s Diseases

    D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)

    Objective: Huntington’s Disease (HD) is a severe neurodegenerative disorder main pathogenic factor is CAG repeats in a suffered patients genome. Experimental therapy on the model…
  • MDS Virtual Congress 2020

    The clinical spectrum of movement disorders associated with neuronal antibodies

    V. Karthikeayan, A. Randall, E. Jackson, S. Huda, M. Bonello (Liverpool, United Kingdom)

    Objective: To describe the clinical and treatment characteristics of movement disorders associated with antibodies (Abs) against neuronal synaptic extracellular (NMDAR, LGI1, CASPR2, IgLON5, Glycine receptors…
  • 2019 International Congress

    A case of cerebellar ataxia caused by Pembrolizumab for Non-small cell lung cancer

    T. Moto, H. Nagayama, K. Kimura (Tokyo, Japan)

    Objective: We reported a case that cerebellar ataxia and decreased accumulation of right cerebellum at SPECT appeared after immunotherapy using immune-checkpoint inhibitor “Pembrolizumab” for Non-small…
  • 2018 International Congress

    Gluten sensitivity in progressive cerebellar ataxia patients from India

    I. Singh, A. Verma, I. Singh, A. Singh, V. Suroliya, U. Hooda, M. Faruq, V. Ahuja, G. Makharia, A. Srivastava (New Delhi, India)

    Objective: To screened a well-defined cohort of patients with cerebellar ataxia for the presence of gluten sensitivity. Background: Cerebellar ataxia is a heterogeneous group of…
  • 2018 International Congress

    mGluR1 antibodies encephalitis: A rare cause of reversible ataxia and myoclonus syndrome

    F. Ory Magne, C. Goillion, J. Dupouy, M. Simonetta, C. Brefel Courbon, O. Rascol, J. (Toulouse, France)

    Objective: We wanted to report the case of a patient with severe subacute cerebellar ataxia related to mGluR1-antibodies with a clear improvement after immunomodulator treatment.…
  • 2018 International Congress

    Antibodies to alpha-Synuclein in Parkinson disease

    D. Labunskiy (Santa Rosa, CA, USA)

    Objective: Alpha-synuclein (α-syn) plays a very important role in pathogenesis of Parkinson’s disease (PD). There are enough evidence of neuroinflammation in the brain tissue of…
  • 2018 International Congress

    Natural occurring antibodies reduce aggregation of α-synuclein

    A. Braczynski, E. Agerschou, Y. Kronimus, W. Hoyer, R. Dodel, B. Falkenburger, J. Schulz, J. Bach (Aachen, Germany)

    Objective: We tested naturally occurring antibodies (nAbs) against α-synuclein both in vitro as well as in HEK293T cells to determine binding, cell viability and capacity…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley